학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 201건 | 목록 1~20
Academic Journal
Powles T; aBarts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust, London, UK.; Tagawa ST; bWeill Cornell Medicine, New York-Presbyterian, New York, NY, USA.; Vulsteke C; cIntegrated Cancer Center Ghent, AZ Maria Middelares, Ghent, Belgium and Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.; Gross-Goupil M; dDepartment of Medical Oncology, University Hospital of Bordeaux - Hôpital St André, Bordeaux, France.; Park SH; eSamsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Necchi A; fVita-Salute San Raffaele University, Milan, Italy.; gIRCCS San Raffaele Hospital, Milan, Italy.; De Santis M; hCharité Universitätsmedizin Berlin, Department of Urology, Berlin, Germany; and Department of Urology, Medical University of Vienna, Vienna, Austria.; Duran I; iDepartment of Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.; Morales-Barrera R; jDepartment of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Barcelona, Spain.; Guo J; kBeijing Cancer Hospital, Beijing, China.; Sternberg CN; bWeill Cornell Medicine, New York-Presbyterian, New York, NY, USA.; Bellmunt J; lDana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Goebell PJ; mDepartment of Urology, University Clinic Erlangen, Erlangen, Germany.; Kovalenko M; nGilead Sciences, Inc., Foster City, CA, USA.; Boateng F; nGilead Sciences, Inc., Foster City, CA, USA.; Sierecki M; nGilead Sciences, Inc., Foster City, CA, USA.; Wang L; nGilead Sciences, Inc., Foster City, CA, USA.; Sima CS; nGilead Sciences, Inc., Foster City, CA, USA.; Waldes J; nGilead Sciences, Inc., Foster City, CA, USA.; Bangs R; oBladder Cancer Advocacy Network, Bethesda, MD, USA.; Loriot Y; pInstitut de Cancérologie Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Grivas P; qDepartment of Medicine, Division of Hematology/Oncology, University of Washington, Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: In Process; MEDLINE
Academic Journal
Loriot Y; Institut de Cancérologie Gustave Roussy, Villejuif, France.; Balar AV; Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Petrylak DP; Smilow Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Kalebasty AR; University of California Irvine, Irvine, California.; Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington.; Fléchon A; Centre Léon Bérard, Lyon, France.; Jain RK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Swami U; Huntsman Cancer Hospital, Salt Lake City, Utah.; Bupathi M; Rocky Mountain Cancer Centers, Littleton, Colorado.; Barthélémy P; Hôpitaux Universitaires de Strasbourg, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Beuzeboc P; Hôpital Foch, Suresnes, France.; Palmbos P; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.; Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Pouessel D; Institut Claudius Regaud/IUCT-Oncopole, Toulouse, France.; Sternberg CN; Weill Cornell Medicine, New York, New York.; Tonelli J; Gilead Sciences, Inc., Parsippany, New Jersey.; Sierecki M; Gilead Sciences, Inc, Foster City, California.; Zavodovskaya M; Gilead Sciences, Inc, Foster City, California.; Elboudwarej E; Gilead Sciences, Inc, Foster City, California.; Diehl L; Gilead Sciences, Inc, Foster City, California.; Jürgensmeier JM; Gilead Sciences, Inc, Foster City, California.; Tagawa ST; Weill Cornell Medicine, New York, New York.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA.; Pouessel D; Department of Medical Oncology & Clinical Research Unit, Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse (IUCT-Oncopôle), Toulouse, France.; Park CH; Norton Cancer Institute, Louisville, KY.; Barthelemy P; Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Bupathi M; Rocky Mountain Cancer Centers, Littleton, CO.; Petrylak DP; Yale School of Medicine, New Haven, CT.; Agarwal N; Huntsman Cancer Institute, Salt Lake City, UT.; Gupta S; Huntsman Cancer Institute, Salt Lake City, UT.; Fléchon A; Centre Léon Bérard, Lyon, France.; Ramamurthy C; University of Texas Health Science Center at San Antonio, San Antonio, TX.; Davis NB; Vanderbilt-Ingram Cancer Center, Nashville, TN.; Recio-Boiles A; University of Arizona Cancer Center, Tucson, AZ.; Sternberg CN; Weill Cornell Medical College of Cornell University, New York, NY.; Bhatia A; Gilead Sciences, Inc, Morris Plains, NJ.; Pichardo C; Gilead Sciences, Inc, Morris Plains, NJ.; Sierecki M; Gilead Sciences, Inc, Morris Plains, NJ.; Tonelli J; Gilead Sciences, Inc, Morris Plains, NJ.; Zhou H; Gilead Sciences, Inc, Morris Plains, NJ.; Tagawa ST; Weill Cornell Medical College of Cornell University, New York, NY.; Loriot Y; Institut de Cancérologie Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Loriot Y; Institut de Cancérologie Gustave Roussy, Villejuif, France.; Kalebasty AR; University of California, Irvine, CA, USA.; Fléchon A; Centre Léon Bérard, Lyon, France.; Jain RK; H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.; Gupta S; Division of Oncology, Department of Medicine, University of Utah's Huntsman Cancer Institute, UT, USA.; Bupathi M; Rocky Mountain Cancer Centers, Littleton, CO, USA.; Beuzeboc P; Hôpital Foch, Suresnes, France.; Palmbos P; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.; Balar AV; Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA.; Kyriakopoulos CE; University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Pouessel D; Institut Claudius Regaud/Cancer Comprehensive Center, IUCT, Oncopole, Toulouse, France.; Sternberg CN; Weill Cornell Medicine, New York, NY, USA.; Tonelli J; Gilead Sciences, Inc., Parsippany, NJ, USA.; Sierecki M; Gilead Sciences, Inc., Parsippany, NJ, USA.; Zhou H; Gilead Sciences, Inc., Parsippany, NJ, USA.; Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA.; Barthélémy P; Hôpitaux Universitaires de Strasbourg/Institut de Cancérologie Strasbourg Europe, Strasbourg, France.; Bangs R; Patient Advocate, Pittsford, New York, NY, USA.; Tagawa ST; Weill Cornell Medicine, New York, NY, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Academic Journal
Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Sandra and Edward Meyer Cancer Center, New York, NY.; Petrylak DP; Yale Cancer Center, New Haven, CT.; Bellmunt J; Beth Israel Deaconess Medical Center and PSMAR-IMIM Lab, Boston, MA.; Harvard Medical School, Boston, MA.; Nishiyama H; Department of Urology, University of Tsukuba, Tsukuba, Japan.; Necchi A; Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.; Gurney H; Clinical Trials Unit FMHS, Macquarie University, Sydney, New South Wales, Australia.; Lee JL; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.; van der Heijden MS; Medical Oncology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Rosenbaum E; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.; Penel N; Lille University and Department of Medical Oncology, Centre Oscar Lambret, Lille, France.; Pang ST; Division of Urology, Department of Surgery, Linkou Chang Gung Memorial Hospital, Linkou, Taiwan.; Li JR; Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.; García Del Muro X; Department of Medical Oncology, University of Barcelona, Idibell Institute of Research, Institut Català d'Oncologia Hospitalet, Barcelona, Spain.; Joly F; Clinical Research Department, Centre François Baclesse, Caen, France.; Pápai Z; Oncology Department, Medical Centre, Hungarian Defence Forces, Budapest, Hungary.; Bao W; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Ellinghaus P; Bayer AG, Wuppertal, Germany.; Lu C; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Sierecki M; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Coppieters S; Bayer AG, Diegem, Belgium.; Nakajima K; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Ishida TC; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Quinn DI; Division of Oncology, Department of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Sierecki, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어